Pediatric LVAD
This article was originally published in The Gray Sheet
Executive Summary
Abiomed announces development plans Jan. 24 for a child-sized, catheter-based heart pump similar to its CE-marked Impella 2.5. The device, currently in pre-clinical studies, is intended to provide left-ventricular support for pediatric patients prior to cardiac surgery, as well as patients who cannot be weaned from bypass or who have endocarditis. Abiomed's Impella 2.5 and Impella 5.0 are in clinical trials in the United States (1"The Gray Sheet" Jan. 22, 2007, p. 13)...